Showing results (211-220 of 4,768) with videos related to

Sort By:
Pageof 477
BMC Pulmonary Medicine|December 31, 2009
Action Plan to enhance self-management and early detection of exacerbations in COPD patients; a multicenter RCTJaap C A Trappenburg, Lieselotte Koevoets, Gerdien H de Weert-van Oene, et al.
BMC Pulmonary Medicine|December 5, 2009
Plasma CC16 levels are associated with development of ALI/ARDS in patients with ventilator-associated pneumonia: a retrospective observational studyRogier M Determann, Julian L Millo, Sam Waddy, et al.
BMC Pulmonary Medicine|November 23, 2017
Long-term prognosis of chronic cough: a prospective, observational cohort studyHeikki O Koskela, Anne M Lätti, Minna K Purokivi
BMC Pulmonary Medicine|November 23, 2017
Effect of sivelestat sodium in patients with acute lung injury or acute respiratory distress syndrome: a meta-analysis of randomized controlled trialsShenglan Pu, Daoxin Wang, Daishun Liu, et al.
BMC Pulmonary Medicine|November 24, 2017
Medical thoracoscopy for exudative pleural effusion: an eight-year experience from a country with a young populationMerlin Thomas, Wanis H Ibrahim, Tasleem Raza, et al.
BMC Pulmonary Medicine|November 19, 2017
Efficacy and safety of nasal high-flow oxygen in COPD patientsHelene Vogelsinger, Michael Halank, Silke Braun, et al.
BMC Pulmonary Medicine|November 19, 2017
Can high-flow nasal cannula reduce the rate of reintubation in adult patients after extubation? A meta-analysisYue-Nan Ni, Jian Luo, He Yu, et al.
BMC Pulmonary Medicine|November 19, 2017
Analytical performance of Envisia: a genomic classifier for usual interstitial pneumoniaYoonha Choi, Jiayi Lu, Zhanzhi Hu, et al.
BMC Pulmonary Medicine|November 9, 2017
Neurally Adjusted Ventilatory Assist (NAVA) or Pressure Support Ventilation (PSV) during spontaneous breathing trials in critically ill patients: a crossover trialJuliana C Ferreira, Fabia Diniz-Silva, Henrique T Moriya, et al.
BMC Pulmonary Medicine|March 18, 2018
Clinical and economic impact of a one-year treatment with omalizumab in patients with severe allergic asthma within a drug programme in PolandKarina Jahnz-Różyk, Joanna Lis, Marta Warchoł, et al.
Pageof 477